Shareprice
01 Dec 2023

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2023

28 August, 2023 FluoGuide A/S issues warrants to the investors participating in the directed share issue News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 28 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
31 July, 2023 FluoGuide A/S issues warrants to Board members, management and employees News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark, 31 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
25 July, 2023 Minutes from Extraordinary General Meeting in FluoGuide A/S News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 25 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held an extraordinary...
7 July, 2023 FluoGuide convenes an extraordinary general meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
Copenhagen, Denmark, 7 July 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
5 July, 2023 FluoGuide completes a Directed Share Issue raising SEK 15 million News Corporate Action Shares Issuance English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
20 June, 2023 FluoGuide announces positive interim results from phase IIa trial of FG001 in head & neck cancer News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
7 June, 2023 FluoGuide announces positive topline results from phase IIa trial of FG001 in lung cancer News Corporate Information Other Corporate Information English IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
31 May, 2023 FluoGuide A/S publishes interim report for the period January – March 2023 News English Regulatory Listing Regulation Report Interim Q1 IR
Copenhagen, Denmark, 31 May 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...
24 May, 2023 FluoGuide provides update on strong clinical trial progress News Corporate Information Other Corporate Information English Regulatory MAR IR
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...

Calendar &
upcoming reports


29 November 2023

Interim report Q3, 2023


8-10 January 2024

SEB Nordic Seminar


31 January 2024

Økonomisk Ugebrev Life Science Investor Conference


28 February 2024

Year end report 2023

Show all posts